Tango Therapeutics to Present Updated Combination Data at ESMO 2026

Tango Therapeutics said it will present updated vopimetostat and RAS(ON) combination data at the ESMO Congress 2026. The company also plans a PDAC-focused investor webcast on October 23, 2026, at 7:30 a.m. ET.